Navigation Links
Specialty Renal Pharmacy Delivers One Millionth Prescription

DaVita Rx brings convenience and personalized care to dialysis patients


DALLAS, Aug. 27 /PRNewswire-FirstCall/ -- DaVita Inc., a leading provider of kidney care services, announced today that its specialty renal pharmacy, DaVita Rx(SM), will deliver its one millionth prescription. The prescription will be filled today during a special celebration at DaVita Rx headquarters in Dallas. DaVita(R) Senior Vice President Gina Randolph and DaVita Vice President of Clinical Support Services Dr. David Van Wyck are on hand while the prescription is packaged for distribution.


DaVita Rx is a pharmacy specializing in the needs of people on dialysis, offering the convenience of dialysis center delivery service at no additional cost along with personalized care to make sure patients are able to receive and take all the medications they need. The Dallas location is its flagship pharmacy, and along with two other pharmacies, it serves over 13,000 dialysis patients in 33 states.

"I had trouble with pharmacies not having my medication ready when I went to pick it up, or my medication being out of stock, or going and they were closed," says a local dialysis patient who uses DaVita Rx. "With DaVita Rx I get it when I need it and I feel healthier."

On average, dialysis patients are prescribed more than eight medications to treat five co-morbid conditions. Research indicates dialysis patients adhere to the medication regimen prescribed by their doctors at a rate of 50-60%. DaVita Rx pharmacists work with DaVita's clinical teammates to drive medication adherence and improve patient outcomes and provides physicians with clear visibility of their patients' medication adherence. With that partnership in place, adherence rates can be 80% or higher.

DaVita Rx also provides kidney patients with an auto-refill program, flexible payment options, help with insurance and 24/7 toll-free access to DaVita Rx pharmacists.

DaVita Rx's one millionth prescription will be delivered to a dialysis center in Los Angeles, Calif. today by DaVita CEO Kent Thiry.

DaVita and DaVita Rx are trademarks or registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,300 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 107,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education and its community programs, please visit

SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Specialty Surgery Center to Partner With Surgical Care Affiliates
2. Most Influential Events for Koreas Fine and Specialty Chemical and Pharmaceutical Industries to be Held in November
3. More Cancer Lymph Nodes Analyzed at Specialty Centers
4. HighPoint Solutions Signs Deal to Implement Model N Managed Care and Government Pricing System for Specialty Pharmaceutical Company
5. Baldor Specialty Foods, Inc. Responds to FDA Tomato Recall
6. Tri-anim and Bound Tree Medical Merge to Create Nations Leading Specialty Health Care Distributor
7. U.S.News & World Report Debuts First Specialty Rankings of Americas Best Childrens Hospitals
8. Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
9. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
10. and Convera(R) Launch Search Site for Physicians in the ObGyn Specialty
11. ACP hosts largest medical education meeting for general and subspecialty internists
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology: